Laboratorios Farma | ROVI - Ordinary Share Capital


Laboratorios Farma reported EUR51.82M in Ordinary Share Capital for its fiscal semester ending in December of 2023.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Almirall EUR 214.79M 0 Dec/2025
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.61M 40K Jun/2026
Pharma Mar EUR 17.34M 24.24K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Viatris USD 1.16B 9.19M Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026